Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for antibody drug discovery, Biocytogen offers animal model generation, antibody fully human-mouse (RenMab mouse), therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO, and regulatory affairs support.

Biotechnology

Biocytogen

Yuelei Shen

James Jin

Wang Yongliang

Bin Liu

Rong Chen

Dirui Li

Sabrina Wang

Zhihong Li

Zhaoxue Yu

Benny Yang

Chaoshe Guo

Jiawei Yao

The Pharmaceutical Research Team at Biocytogen specializes in advancing therapeutic antibody candidates from concept to early-stage development. Utilizing expertise in pharmacology and gene editing, the team conducts preclinical studies and develops cutting-edge animal models, such as the fully human RenMab mouse, to evaluate drug efficacy and safety. They also play a vital role in regulatory strategy, ensuring compliance and facilitating smooth transitions to IND applications.

Pharmaceutical Research Team

Business Development Team

Leadership Team

Pharmaceutical Research Team

About

Team members

Other teams at Biocytogen

Business Development Team

Leadership Team